New York, NY -- (SBWIRE) -- 06/12/2017 -- The analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/526645-global-cancer-diagnostics-device-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Diagnostics
- Agilent Technologies
- BD
- bioMérieux
- Qiagen
- Roche Diagnostics

Other prominent vendors
- Affymetrix
- Ambry Genetics
- Annoroad
- Aviva Biosciences
- Biochain
- Bio-Rad
- Cancer Genetics
- Cepheid
- CompanionDx
- DiagnoCure
- Epic Sciences
- Epigenomics
- Genomic Health
- HalioDX
- Hologic
- Illumina
- Myriad Genetics
- Thermo Fisher Scientific
- Ventana Medical Systems
- Vysis

Market driver
- Demand for personalized medicines
- For a full, detailed list, view our report

Market challenge
- High cost of developing companion diagnostics
- For a full, detailed list, view our report

Market trend
- Demand for personalized medicines
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Ask Query @ https://www.wiseguyreports.com/enquiry/526645-global-cancer-diagnostics-device-market-2016-2020

Table Of Contents – Major Key Points

PART 01: Executive summary
- Highlights

PART 02: Scope of the report
- Market overview
- Top-vendor offerings

PART 03: Market research methodology
- Research methodology
- Economic indicators

PART 04: Introduction
- Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 07: Reimbursement and coverage: An overview
- Current scenario: Validating diagnostic tests
- Reimbursement structure in US
- Reimbursement structure in EU

PART 08: Cancer diagnostic devices: Pricing scenario

PART 09: Market segmentation by product
- Global companion cancer diagnostic devices market
- Global molecular cancer diagnostic devices market

PART 10: Market segmentation by cancer type
- Lung cancer
- Breast cancer
- Colorectal cancer
- Prostate cancer
- Cervical cancer

PART 11: Geographical segmentation
- Cancer diagnostic devices market in Americas
- Cancer diagnostic devices market in EMEA
- Cancer diagnostic devices market in APAC

PART 12: Market drivers
- Prevalence of cancer
- Need for cost-cutting in drug discovery and development
- Demand for personalized medicines
- Advances in technology
- Focus on emerging countries

Continued…….

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=526645

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories.